| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/13/2005 | CN1638740A Modified release dosage forms |
| 07/13/2005 | CN1638739A Compound for treating assuetude disturbance |
| 07/13/2005 | CN1638737A Oral dosage form for propiverine or its pharmaceutically acceptable salts with an extended release of the active ingredient |
| 07/13/2005 | CN1638736A Composition and methods for treatment of hyperplasia |
| 07/13/2005 | CN1638734A Drug delivery system for the subconjunctival administration of fine grains |
| 07/13/2005 | CN1638732A Sustained release drug formulations containing a carrier peptide |
| 07/13/2005 | CN1638731A Aerosol formulations for pulmonary administration of medicaments to produce a systemic effect |
| 07/13/2005 | CN1638730A Formoterol superfine formulation |
| 07/13/2005 | CN1638729A Pressurised metered dose inhalers containing solutions of beta-2 agonists |
| 07/13/2005 | CN1638728A Powder inhalation containing CGRP-antagonist BIBN4096 and method for the production thereof |
| 07/13/2005 | CN1638650A Composition improving age-related physiological deficits and increasing longevity |
| 07/13/2005 | CN1638633A Agonists and antagonists of 5h3-like receptors of invertebrates as pesticides |
| 07/13/2005 | CN1637149A Novel use |
| 07/13/2005 | CN1637018A Novel effectors of dipeptidyl peptidase IV |
| 07/13/2005 | CN1637016A Non-aromatic estrogenic steroids with a hydrocarbon substituent in position 11 |
| 07/13/2005 | CN1637015A 17alpha-alkyl-17beta-oxy-estratrienes, uses thereof and pharmaceutical preparations |
| 07/13/2005 | CN1637013A Modified cpg oligodeoxynucleotide with improved immunoregulatory function |
| 07/13/2005 | CN1637011A Avermectin derivatives |
| 07/13/2005 | CN1637010A Extraction and application of paeonol amygdaloside |
| 07/13/2005 | CN1637009A Extraction process of total rehmannioside |
| 07/13/2005 | CN1637002A Cephalosporin ester compound resisting beta-lactamase and its salt |
| 07/13/2005 | CN1636997A Substituted tricyclocoumarin compound and its prepn and anti-HIV application |
| 07/13/2005 | CN1636996A Diazabicyclic derivatives as nicotinic acetylcholine receptor ligands |
| 07/13/2005 | CN1636994A Process of preparing alkali metal salys of hydrophobic sulfonamides and alkali metal salt produced thereby |
| 07/13/2005 | CN1636993A Process for producing novel form of paroxetine hydrochloride anhydrate |
| 07/13/2005 | CN1636992A Process for producing quinazoline ditosylate salt compounds |
| 07/13/2005 | CN1636991A Sodium-hydrogen exchanger type 1 inhibitor crystals |
| 07/13/2005 | CN1636990A Heterocyclic substituted aminoazacycles useful as central nervous system agents |
| 07/13/2005 | CN1636986A Benzophenones as inhibitors of reverse transcriptase |
| 07/13/2005 | CN1636985A Benzophenones as inhibitors of reverse transcriptase |
| 07/13/2005 | CN1636984A Benzophenones as inhibitors of reverse transcriptase |
| 07/13/2005 | CN1636983A Substituted heterocyclic compounds |
| 07/13/2005 | CN1636980A 二肽腈组织蛋白酶k抑制剂 Dipeptide nitrile cathepsin inhibitors k |
| 07/13/2005 | CN1636978A Pyrrolidinyl metalloprotease inhibitor and its application |
| 07/13/2005 | CN1636977A 1, 3-disubstituted pyrrolidines as alpha-2-adrenoceptor antagonists |
| 07/13/2005 | CN1636976A Mutilin derivatives and their use as antibacterials |
| 07/13/2005 | CN1636967A Noval compounds, their use and preparation |
| 07/13/2005 | CN1636600A 皮肤外用制剂 External preparation for skin |
| 07/13/2005 | CN1636599A Medicine composition and kit for local narcosis or relieving pain |
| 07/13/2005 | CN1636598A Methods to potentiate intravenous estramustine phosphate |
| 07/13/2005 | CN1636597A Compounds for the treatment of female sexual dysfunction |
| 07/13/2005 | CN1636593A Novel effectors of dipeptidyl peptidase IV |
| 07/13/2005 | CN1636588A Red yeast prepn containing active components of glossy ganoderma and its prepn process |
| 07/13/2005 | CN1636579A Hypoglycemic Chinese medicine prepn and its production process |
| 07/13/2005 | CN1636577A Vaginal care composition |
| 07/13/2005 | CN1636575A Application of CMC grafted polyacrylic acid in preparing hemostatic and hemostatic material |
| 07/13/2005 | CN1636574A Lipase inhibiting polymers |
| 07/13/2005 | CN1636573A Vitamin-medicine composition and its use |
| 07/13/2005 | CN1636572A Compositions and methods for treatment of mitochondrial diseases |
| 07/13/2005 | CN1636571A Use of New Zealand vitexin-1 in preparing antiviral medicine |
| 07/13/2005 | CN1636570A Use of New Zealand vitexin-1 in preparing antiviral medicine |
| 07/13/2005 | CN1636569A Application of total araloside in preparing analgetic |
| 07/13/2005 | CN1636568A Eye drop of tobramycin and sodium hyaluronate and its prepn process |
| 07/13/2005 | CN1636567A Piperazine derivative used as CCRS antagonist |
| 07/13/2005 | CN1636566A Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors |
| 07/13/2005 | CN1636565A Modified form of the r(-)-n-(4, 4-di(3-methylthien-2-yl)but-3-enyl)-nipecotic acid hydrochloride |
| 07/13/2005 | CN1636564A Alkoxy substituted benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same |
| 07/13/2005 | CN1636563A 噻唑衍生物 Thiazole derivatives |
| 07/13/2005 | CN1636562A Use of fluorinated triazoles in treating affective and attention disorders |
| 07/13/2005 | CN1636561A Use of at-1 receptor antagonist for treating diseases associated with an increase of at-1 receptors |
| 07/13/2005 | CN1636560A Injectable taxane derivative based compositions |
| 07/13/2005 | CN1636559A Ethers of o-desmethyl venlafaxine |
| 07/13/2005 | CN1636558A Tablet containing brufen and producing process thereof |
| 07/13/2005 | CN1636557A Simple production process for zinc citrate, zinc lactate, ferrous citrate and ferrous lactate |
| 07/13/2005 | CN1636556A Compound coenzyme-Q10 prepn |
| 07/13/2005 | CN1636555A Transdermal drug delivery matrix for coadministering estradiol and another steroid |
| 07/13/2005 | CN1636554A Process for producing soft gelatin capsule |
| 07/13/2005 | CN1636553A Volatile proof solid preparation and producing method thereof |
| 07/13/2005 | CN1636552A Ascending-dose dosage form |
| 07/13/2005 | CN1636549A Oil-in-water emulsion composition |
| 07/13/2005 | CN1636547A Stabilized compositions containing an oxygen-labile active agent |
| 07/13/2005 | CN1636463A Food product and process for manufacturing same |
| 07/13/2005 | CN1636453A Use of naphtoquinone compounds for the preparation of biocidal compositions and derivative composition |
| 07/13/2005 | CN1210407C Aglucone isoflavone enriched vegetable protein extract and protein material, and high genistein and daidzein content materials and process for producing the same |
| 07/13/2005 | CN1210401C Compound from moraxella catarrhalis |
| 07/13/2005 | CN1210289C Radde anemone rhizome extract and its prepn process and use |
| 07/13/2005 | CN1210281C Titanium derived compounds, rpeparation an use thereof |
| 07/13/2005 | CN1210279C Thiazolo (4,5-D) pyrimidine compounds |
| 07/13/2005 | CN1210277C Heteroaryl diazabicycloalkanes, their prepn. and use |
| 07/13/2005 | CN1210275C Respiratory syncytial virus replication inhibitors |
| 07/13/2005 | CN1210274C Piperazine and piperidine derivatives |
| 07/13/2005 | CN1210273C Substituted 3-pyridyl-4-arylpyrroles, and related therapeutic and prophylactic methods |
| 07/13/2005 | CN1210272C Non-steroidal polycyclic ring sulphamate derivs, their preparation and their use as oestrone sulphatase inhibitors |
| 07/13/2005 | CN1210270C Novel use of phenylheteroalkylamine derivatives |
| 07/13/2005 | CN1210268C (Cyclo) alkyl substituted-gamma-aminobutyric acid derivatives (=GABA analogurs), their preparation and their use in the treatment of neurolog disorders |
| 07/13/2005 | CN1210267C 2-hydroxy-mutilin carbamate derivatives for antibacterial use |
| 07/13/2005 | CN1210266C Crystalline salts of 7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl (methysulfonyl)amino]pyrimidin-5-yl]-(3R5S)-3,5-dihydroxyhept-6-enojc acid |
| 07/13/2005 | CN1210265C Phthalazine derivatives and remedies for erectile dysfunction |
| 07/13/2005 | CN1210263C N-hydroxy-2-(alkyl, aryl or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors |
| 07/13/2005 | CN1210262C Method for preparing methylsulfonate trihydrate of 1-(4-hydroxyphenyl)-2-(4-hydroxy-4-phenylpiperid-1-yl)-1-propanol |
| 07/13/2005 | CN1210261C Arylpiperidine and aryl-1,2,5,6-tetrahydropyridine amide derivatives having 5HT1A receptor activity |
| 07/13/2005 | CN1210260C Crystalline forms of fluvastatin sodium |
| 07/13/2005 | CN1210258C Glyburide composition |
| 07/13/2005 | CN1210256C Diacylhydrazine derivs |
| 07/13/2005 | CN1210251C Substituted nor bornylamion derivatives, method for production thereof, use thereof and medicaments containing said compounds |
| 07/13/2005 | CN1210250C Benzene derivatives, preparation method and pharmaceutical compositions containing same |
| 07/13/2005 | CN1210065C Solid dispersion system with Pranlukast for improving dissolution, and the preparing method thereof |
| 07/13/2005 | CN1210064C Compositions for the treatment of coccidiosis |
| 07/13/2005 | CN1210063C Complex local medicine for mainly treating oral ulcer |
| 07/13/2005 | CN1210055C Moschus safflower capsules for treating femoral necrosis, myelitis and fracture |